N@N

Micrus Endovascular to Present at June Investment Conferences

_{//health-fitness.news-articles.net/content/2010/ .. r-to-present-at-june-investment-conferences.html}
^{Published in Health and Fitness on Thursday, June 3rd 2010 at 12:05 GMT by Market Wire}  

SAN JOSE, Calif.--([ BUSINESS WIRE ])--Micrus Endovascular Corporation (NASDAQ:MEND) today announced that senior management will present at three investment conferences in June:

• Robert Stern, President and Chief Operating Officer, will present at Noble Financiala�s Sixth Annual Equity Conference on Monday, June 7, 2010, at 4:30 p.m. Eastern time (1:30 p.m. Pacific time) at the Hard Rock Hotel & Casino in Hollywood, Florida;
• John Kilcoyne, Chairman and Chief Executive Officer, will present at the Jefferies 2010 Global Life Sciences Conference on Wednesday, June 9, 2010, at 1:00 p.m. Eastern time (10:00 a.m. Pacific time) in New YorkCity; and
• Mr. Kilcoyne also will present at the 9^th Annual Needham Healthcare Conference on Thursday, June 10, 2010, at 10:00 a.m. Eastern time (7:00 a.m. Pacific time) at the New York Palace Hotel in New York City.

Live webcasts of these conference presentations will be available via the Internet by visiting the Investor Relations section of Micrusa� Web site at [ www.micruscorp.com ]. Archived presentations will be available on the Companya�s Web site for 14 days.

About Micrus Endovascular Corporation

Micrus develops, manufactures and markets implantable and disposable medical devices for use in the treatment of cerebral vascular diseases. Micrus products are used by interventional neuroradiologists, interventional neurologists and endovascularly trained neurosurgeons to treat both cerebral aneurysms responsible for hemorrhagic stroke and intracranial atherosclerosis, which may lead to ischemic stroke. Hemorrhagic and ischemic stroke are both significant causes of death and disability worldwide. The Micrus product lines enable physicians to gain access to the brain in a minimally invasive manner through the vessels of the arterial system. Micrusa� proprietary, three-dimensional microcoils anatomically deploy within the aneurysm, forming a scaffold that conforms to a wide diversity of aneurysm shapes and sizes. Micrus also sells stents, balloon catheters, access devices such as guide catheters, microcatheters, guidewires and accessory products used in conjunction with its microcoils. For more information, visit [ www.micruscorp.com ].